- Home
- CDE vs INSP Comparison
CDE vs INSP Comparison
Compare CDE & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDE
- INSP
- Stock Information
- Founded
- CDE 1928
- INSP 2007
- Country
- CDE United States
- INSP United States
- Employees
- CDE N/A
- INSP N/A
- Industry
- CDE Precious Metals
- INSP Medical/Dental Instruments
- Sector
- CDE Basic Materials
- INSP Health Care
- Exchange
- CDE Nasdaq
- INSP Nasdaq
- Market Cap
- CDE 4.9B
- INSP 4.6B
- IPO Year
- CDE N/A
- INSP 2018
- Fundamental
- Price
- CDE $8.82
- INSP $130.99
- Analyst Decision
- CDE Strong Buy
- INSP Buy
- Analyst Count
- CDE 4
- INSP 12
- Target Price
- CDE $8.00
- INSP $213.75
- AVG Volume (30 Days)
- CDE 15.4M
- INSP 568.8K
- Earning Date
- CDE 08-06-2025
- INSP 08-05-2025
- Dividend Yield
- CDE N/A
- INSP N/A
- EPS Growth
- CDE N/A
- INSP N/A
- EPS
- CDE 0.28
- INSP 2.17
- Revenue
- CDE $1,201,008,000.00
- INSP $840,111,000.00
- Revenue This Year
- CDE $66.13
- INSP $20.61
- Revenue Next Year
- CDE $2.80
- INSP $17.32
- P/E Ratio
- CDE $31.10
- INSP $61.18
- Revenue Growth
- CDE 41.80
- INSP 27.11
- 52 Week Low
- CDE $4.57
- INSP $123.00
- 52 Week High
- CDE $9.69
- INSP $225.00
- Technical
- Relative Strength Index (RSI)
- CDE 62.68
- INSP 37.93
- Support Level
- CDE $9.03
- INSP $126.01
- Resistance Level
- CDE $9.30
- INSP $138.94
- Average True Range (ATR)
- CDE 0.31
- INSP 4.90
- MACD
- CDE -0.09
- INSP -0.07
- Stochastic Oscillator
- CDE 50.00
- INSP 37.71
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.